NCT04428606View on ClinicalTrials.gov

Study to Determine the Effect of Synbiotics in Patients With Pre-diabetes

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

June 1, 2022

Conditions
PreDiabetes
Interventions
DIETARY_SUPPLEMENT

Metabolic Rheostat

Metabolic Rheostat™ Ingredients: Ginseng extract, Ginseng root extract, berberine chloride, Livaux (gold kiwi powder), MegaSporeBiotic, and MenaquinGold (vitamin K2-7) powder

DIETARY_SUPPLEMENT

Butyrate Ultra

An anerobic probiotic supplement that contains butyrate-producing Butyricicoccus pullicaecorum 25-3T, vitamin K2, and fenugreek to maintain healthy glucose balance.

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

90095

UCLA Center for Human Nutrition, 1000 Veteran Ave., Los Angeles

All Listed Sponsors
lead

Zhaoping Li

OTHER

NCT04428606 - Study to Determine the Effect of Synbiotics in Patients With Pre-diabetes | Biotech Hunter | Biotech Hunter